ResearcherZhejiang UniversityNo recent work listed

Yang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8200-1546; OpenAlex author ID A5025738875. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper

Papers 1

Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. Co-author DOI 10.1002/smll.201602697 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qinglian Hu · 1 shared paper, 2017 · strength 0.07
- Paper Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. DOI 10.1002/smll.201602697 ↗
Qi Zheng Yao · 1 shared paper, 2017 · strength 0.07
- Paper Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. DOI 10.1002/smll.201602697 ↗
Youqing Shen · 1 shared paper, 2017 · strength 0.07
- Paper Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. DOI 10.1002/smll.201602697 ↗
Guping Tang · 1 shared paper, 2017 · strength 0.07
- Paper Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. DOI 10.1002/smll.201602697 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.